US Patent 8389689 Anti-GLP-1R antibodies and their uses
Patent 8389689 was granted and assigned to Janssen Biotech on March, 2013 by the United States Patent and Trademark Office.
All edits
Edits on 18 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 1 Feb, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 29 Nov, 2023
Golden AI
Edits made to:
Article (+118 characters)
Article
Patent abstract
The present invention relates to antibodies reactive with GLP-1R, and methods of making and using them.
Edits on 11 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08389689 Anti-GLP-1R antibodies and their uses US Patent 8389689 Anti-GLP-1R antibodies and their uses
Infobox
Patent Number
0838968900
Patent Number
838968900
Edits on 3 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
083896890
Date of Patent
March 5, 2013
0Patent Application Number
129134060
Date Filed
October 27, 2010
0Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
083896890
Date of Patent
March 5, 2013
0Patent Application Number
129134060
Date Filed
October 27, 2010
0Patent Primary Examiner
Edits on 16 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08389689 Anti-GLP-1R antibodies and their uses
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08389689
Date of patent
March 5, 2013
Patent application number
12913406
Date Filed
October 27, 2010
Patent primary examiner
Find more entities like US Patent 8389689 Anti-GLP-1R antibodies and their uses
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
